Literature DB >> 14978361

Repeated treatment with the traditional medicine Unsei-in inhibits substance P-induced itch-associated responses through downregulation of the expression of nitric oxide synthase 1 in mice.

Tsugunobu Andoh1, Ali Al-Akeel, Kenichiro Tsujii, Hiroshi Nojima, Yasushi Kuraishi.   

Abstract

Unsei-in inhibits substance P (SP)-induced scratching of mice after repeated administration. The involvement of cutaneous nitric oxide (NO) in the SP-induced scratching led us to investigate the effects of Unsei-in on the cutaneous NO system in mice. Seven-day oral administration of Unsei-in (300, but not 100, mg/kg daily) significantly inhibited scratching and the increase of cutaneous NO after intradermal SP injection. The NO synthase 1 (NOS1) inhibitor 7-nitroindazole (1 nmol/site) decreased SP-induced scratching and NO production. Repeated administration of Unsei-in (300 mg/kg) reduced the cutaneous NOS1 level. The results suggest that the inhibition of cutaneous NOS1 expression and NO production participates in the antipruritic action of Unsei-in.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978361     DOI: 10.1254/jphs.94.207

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  3 in total

1.  Unseiin, a Kampo medicine, Reduces the Severity and Manifestations of Skin Toxicities Induced by Cetuximab: A Case Report.

Authors:  Kenkichiro Taira; Kazunori Fujiwara; Takahiro Fukuhara; Tsuyoshi Morisaki; Satoshi Koyama; Ryohei Donishi; Hiromi Takeuchi
Journal:  Yonago Acta Med       Date:  2020-11-24       Impact factor: 1.641

2.  Simultaneous Analysis of 19 Marker Components for Quality Control of Oncheong-Eum Using HPLC-DAD.

Authors:  Chang-Seob Seo; Hyeun-Kyoo Shin
Journal:  Molecules       Date:  2022-05-06       Impact factor: 4.927

Review 3.  Treatment Options for Troublesome Itch.

Authors:  Sumika Toyama; Mitsutoshi Tominaga; Kenji Takamori
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.